Last reviewed · How we verify

NCT05348005

Use of TENS Unit in the Management of Endometriosis Pain

Completed NA Last updated 20 October 2025
What this trial tests

NA trial testing Ovira Transcutaneous Electrical Nerve Stimulation Unit in Endometriosis in 40 participants. Completed in 16 July 2025.

Timeline
28 July 2022
Primary endpoint
16 July 2025
16 July 2025

Quick facts

Lead sponsorMilton S. Hershey Medical Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designcrossover
Maskingnone
Primary purposesupportive care
Enrollment40
Start date28 July 2022
Primary completion16 July 2025
Estimated completion16 July 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Milton S. Hershey Medical Center

Who can join

Adults 18 to 45, female only, with Endometriosis or Pelvic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is see if Transcutaneous Electrical Nerve Stimulator (TENS) units help decrease endometriosis flare pain. TENS units have a 510K and are intended for relief of pain associated with sore or aching muscles of the lower back, arms, or legs due to strain from exercise or normal household and work activities. Participants will complete surveys, record pain, medication use and bleeding in an online diary during endometriosis flare ups for 3 months without using the TENS unit. After the first 3 month period of time, a TENS unit will be given to participants to wear and again, record pain, medication use and bleeding in the online diary during endometriosis flare ups for and additional 3 months while using the TENS unit.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Endometriosis

Currently open trials in the same condition.

Other Milton S. Hershey Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05348005.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing